IT1294967B1 - Composizione immunogenica da tlp - Google Patents

Composizione immunogenica da tlp

Info

Publication number: IT1294967B1
Authority: IT; Italy
Prior art keywords: seq; tlp; immunogenic composition; uro; peptides
Prior art date: 1996-10-09

Application number

IT96RM000687A

Other languages

English (en)

Inventor

Giulio Tarro

Original Assignee

Ist Farmacoterapico It Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-09

Filing date

1996-10-09

Publication date

1999-04-23

1996-10-09 Priority to IT96RM000687A priority Critical patent/IT1294967B1/it

1996-10-09 Application filed by Ist Farmacoterapico It Spa filed Critical Ist Farmacoterapico It Spa

1997-10-09 Priority to DK97945086T priority patent/DK0938329T3/da

1997-10-09 Priority to PT97945086T priority patent/PT938329E/pt

1997-10-09 Priority to CN97180260A priority patent/CN1239431A/zh

1997-10-09 Priority to ES97945086T priority patent/ES2138574T3/es

1997-10-09 Priority to KR1019990703053A priority patent/KR20000048995A/ko

1997-10-09 Priority to US09/284,051 priority patent/US20020031531A1/en

1997-10-09 Priority to IL12936897A priority patent/IL129368A0/xx

1997-10-09 Priority to CA002267905A priority patent/CA2267905A1/en

1997-10-09 Priority to DE0938329T priority patent/DE938329T1/de

1997-10-09 Priority to AT97945086T priority patent/ATE218064T1/de

1997-10-09 Priority to EP97945086A priority patent/EP0938329B1/en

1997-10-09 Priority to PCT/IT1997/000240 priority patent/WO1998015282A1/en

1997-10-09 Priority to RU98112608/14A priority patent/RU2192274C2/ru

1997-10-09 Priority to AU46376/97A priority patent/AU725218B2/en

1997-10-09 Priority to JP51736198A priority patent/JP2001508764A/ja

1997-10-09 Priority to DE69712907T priority patent/DE69712907T2/de

1998-04-09 Publication of ITRM960687A1 publication Critical patent/ITRM960687A1/it

1999-04-08 Priority to NO991653A priority patent/NO991653L/no

1999-04-23 Application granted granted Critical

1999-04-23 Publication of IT1294967B1 publication Critical patent/IT1294967B1/it

2003-07-31 Priority to US10/631,838 priority patent/US20040022870A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/86—Lung
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
- A61K2239/55—Lung

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

IT96RM000687A 1996-10-09 1996-10-09 Composizione immunogenica da tlp IT1294967B1 (it)

Priority Applications (19)

Application Number	Priority Date	Filing Date	Title
IT96RM000687A IT1294967B1 (it)	1996-10-09	1996-10-09	Composizione immunogenica da tlp
PCT/IT1997/000240 WO1998015282A1 (en)	1996-10-09	1997-10-09	Immunogenic tlp composition
CN97180260A CN1239431A (zh)	1996-10-09	1997-10-09	致免疫的tlp组合物
ES97945086T ES2138574T3 (es)	1996-10-09	1997-10-09	Composicion inmunogenica a base de particulas liberadas por el tumor.
KR1019990703053A KR20000048995A (ko)	1996-10-09	1997-10-09	면역원 ｔｌｐ 조성물
US09/284,051 US20020031531A1 (en)	1996-10-09	1997-10-09	Immunogenic tlp composition
IL12936897A IL129368A0 (en)	1996-10-09	1997-10-09	Immunogenic TLP composition
CA002267905A CA2267905A1 (en)	1996-10-09	1997-10-09	Immunogenic tlp composition
DK97945086T DK0938329T3 (da)	1996-10-09	1997-10-09	Immunogen TLP sammensætning
AT97945086T ATE218064T1 (de)	1996-10-09	1997-10-09	Immunogene tlp-zusammensetzung
EP97945086A EP0938329B1 (en)	1996-10-09	1997-10-09	Immunogenic tlp composition
PT97945086T PT938329E (pt)	1996-10-09	1997-10-09	Composicao de tlp imunogenica
RU98112608/14A RU2192274C2 (ru)	1996-10-09	1997-10-09	Иммуногенная композиция на основе tlp
AU46376/97A AU725218B2 (en)	1996-10-09	1997-10-09	Immunogenic TLP composition
JP51736198A JP2001508764A (ja)	1996-10-09	1997-10-09	免疫原性ｔｌｐ組成物
DE69712907T DE69712907T2 (de)	1996-10-09	1997-10-09	Immunogene tlp-zusammensetzung
DE0938329T DE938329T1 (de)	1996-10-09	1997-10-09	Immunogene tlp-zusammensetzung
NO991653A NO991653L (no)	1996-10-09	1999-04-08	Immunogenisk tumor frigjorte partikler (TLP)-blanding
US10/631,838 US20040022870A1 (en)	1996-10-09	2003-07-31	Immunogenic TLP composition

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT96RM000687A IT1294967B1 (it)	1996-10-09	1996-10-09	Composizione immunogenica da tlp

Publications (2)

Publication Number	Publication Date
ITRM960687A1 ITRM960687A1 (it)	1998-04-09
IT1294967B1 true IT1294967B1 (it)	1999-04-23

Family

ID=11404462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT96RM000687A IT1294967B1 (it)	1996-10-09	1996-10-09	Composizione immunogenica da tlp

Country Status (17)

Country	Link
US (2)	US20020031531A1 (it)
EP (1)	EP0938329B1 (it)
JP (1)	JP2001508764A (it)
KR (1)	KR20000048995A (it)
CN (1)	CN1239431A (it)
AT (1)	ATE218064T1 (it)
AU (1)	AU725218B2 (it)
CA (1)	CA2267905A1 (it)
DE (2)	DE938329T1 (it)
DK (1)	DK0938329T3 (it)
ES (1)	ES2138574T3 (it)
IL (1)	IL129368A0 (it)
IT (1)	IT1294967B1 (it)
NO (1)	NO991653L (it)
PT (1)	PT938329E (it)
RU (1)	RU2192274C2 (it)
WO (1)	WO1998015282A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1317853B1 (it) *	2000-02-25	2003-07-15	Unihart Corp	Peptidi tlp e sequenze di dna che li codificano.
RU2192884C2 (ru) *	2000-11-09	2002-11-20	Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН	Вакцина для стимуляции противоопухолевого иммунитета
DE10115740A1 (de)	2001-03-26	2002-10-02	Ulrich Speck	Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de)	2002-09-20	2004-04-01	Ulrich Prof. Dr. Speck	Medizinische Vorrichtung zur Arzneimittelabgabe
CA2593086A1 (en)	2004-12-30	2006-07-06	Vito Michele Fazio	Anti-tumoral immunogenic peptides and vaccine thereof
EP2252690A2 (en) *	2007-12-21	2010-11-24	Coda Therapeutics, Inc.	Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
ITRM20100256A1 (it) *	2010-05-19	2011-11-20	Farmafin Spa	Un nuovo biomarcatore per la diagnosi precoce e l'immunoterapia del cancro
EP3167898A1 (en)	2015-11-11	2017-05-17	IEO - Istituto Europeo di Oncologia Srl	Method for obtaining tumor peptides and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1206250B (it) *	1987-02-18	1989-04-14	Ist Farmacoterapico It Spa	Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
IT1262954B (it) *	1992-07-03	1996-07-23	Ist Farmacoterapico It Spa	Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

1996
- 1996-10-09 IT IT96RM000687A patent/IT1294967B1/it active IP Right Grant
1997
- 1997-10-09 US US09/284,051 patent/US20020031531A1/en not_active Abandoned
- 1997-10-09 DE DE0938329T patent/DE938329T1/de active Pending
- 1997-10-09 PT PT97945086T patent/PT938329E/pt unknown
- 1997-10-09 KR KR1019990703053A patent/KR20000048995A/ko not_active Ceased
- 1997-10-09 WO PCT/IT1997/000240 patent/WO1998015282A1/en not_active Application Discontinuation
- 1997-10-09 DE DE69712907T patent/DE69712907T2/de not_active Expired - Fee Related
- 1997-10-09 EP EP97945086A patent/EP0938329B1/en not_active Expired - Lifetime
- 1997-10-09 DK DK97945086T patent/DK0938329T3/da active
- 1997-10-09 AT AT97945086T patent/ATE218064T1/de not_active IP Right Cessation
- 1997-10-09 AU AU46376/97A patent/AU725218B2/en not_active Ceased
- 1997-10-09 ES ES97945086T patent/ES2138574T3/es not_active Expired - Lifetime
- 1997-10-09 CA CA002267905A patent/CA2267905A1/en not_active Abandoned
- 1997-10-09 CN CN97180260A patent/CN1239431A/zh active Pending
- 1997-10-09 RU RU98112608/14A patent/RU2192274C2/ru not_active IP Right Cessation
- 1997-10-09 IL IL12936897A patent/IL129368A0/xx unknown
- 1997-10-09 JP JP51736198A patent/JP2001508764A/ja active Pending
1999
- 1999-04-08 NO NO991653A patent/NO991653L/no not_active Application Discontinuation
2003
- 2003-07-31 US US10/631,838 patent/US20040022870A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2192274C2 (ru)	2002-11-10
WO1998015282A1 (en)	1998-04-16
PT938329E (pt)	2002-10-31
CN1239431A (zh)	1999-12-22
JP2001508764A (ja)	2001-07-03
AU725218B2 (en)	2000-10-05
NO991653D0 (no)	1999-04-08
EP0938329A1 (en)	1999-09-01
DE69712907D1 (de)	2002-07-04
IL129368A0 (en)	2000-02-17
KR20000048995A (ko)	2000-07-25
AU4637697A (en)	1998-05-05
ATE218064T1 (de)	2002-06-15
DE938329T1 (de)	2000-04-06
US20020031531A1 (en)	2002-03-14
NO991653L (no)	1999-06-08
US20040022870A1 (en)	2004-02-05
ITRM960687A1 (it)	1998-04-09
DK0938329T3 (da)	2002-09-09
CA2267905A1 (en)	1998-04-16
EP0938329B1 (en)	2002-05-29
ES2138574T3 (es)	2002-11-01
DE69712907T2 (de)	2002-12-12
ES2138574T1 (es)	2000-01-16

Publication	Publication Date	Title
HUP9901186A2 (hu)	1999-07-28	Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
EP2258383A3 (en)	2011-05-11	Antigenic peptides derived from telomerase
NZ516381A (en)	2004-03-26	Lung tumor proteins in the therapy and diagnosis of lung cancer
DE69731373D1 (de)	2004-12-02	Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
WO1998033509A3 (en)	1999-03-11	Useful properties of human lactoferrin and variants thereof
DE69922822D1 (de)	2005-01-27	Rekombinante haarbehandlungsmittel
ATE198050T1 (de)	2000-12-15	Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
AU6020099A (en)	2000-03-14	Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
CA2234263A1 (fr)	1998-02-05	Composition pharmaceutique contre les tumeurs et infections a papillomavirus
DE69931482D1 (de)	2006-06-29	Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
IT1294967B1 (it)	1999-04-23	Composizione immunogenica da tlp
DE3584775D1 (de)	1992-01-09	Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
ATE453667T1 (de)	2010-01-15	Neovaskular-spezifische peptide
PT782630E (pt)	2006-06-30	Gene da doenca poliquistica do rim
UA83989C2 (ru)	2008-09-10	Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
GB2357507A (en)	2001-06-27	Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
ATE312923T1 (de)	2005-12-15	Moraxella catarrhalis basb034 polypeptide und verwendungen davon
TR199700842T1 (xx)	1998-01-21	�nsan DNase I Varyantlar�.
ATE230027T1 (de)	2003-01-15	Menschliche dnase i varianten
WO2004089980A3 (en)	2004-11-18	Therapeutic cancer vaccine
WO2000026362A3 (de)	2000-06-22	Proteine der stomatinfamilie und ihre verwendung als zielproteine für die schmerztherapie
DE69827880D1 (de)	2005-01-05	Iga1-protease fragment als trägerpeptid
BR9916771A (pt)	2001-11-13	Composição tlp imunogência
DK1158050T3 (da)	2005-11-28	Human cysteinyl-leukotrienreceptor (CysLT2)
MX9700199A (es)	1998-01-31	Composiciones de cadena invariante utiles para tratar enfermedades autoinmunes.

Legal Events

Date	Code	Title	Description
1999-04-23	0001	Granted